Rapt Therapeutics Inc (RAPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 0 | 1,527 | 3,813 | 5,042 |
| Gross Profit | N/A | N/A | 1,527 | 3,813 | 5,042 |
| Operating Expenses | 136,101 | 127,062 | 87,322 | 73,022 | 58,256 |
| Operating Income | -136,101 | -127,062 | -85,795 | -69,209 | -53,214 |
| Other Income | 6,236 | 10,264 | 1,957 | 5 | 1,312 |
| Pre-tax Income | -129,865 | -116,798 | -83,838 | -69,204 | -51,902 |
| Income Tax | N/A | N/A | N/A | N/A | 990 |
| Net Income Continuous | -129,865 | -116,798 | -83,838 | -69,204 | -52,892 |
| Net Income | $-129,865 | $-116,798 | $-83,838 | $-69,204 | $-52,892 |
| EPS Basic Total Ops | -25.52 | -24.40 | -20.64 | -20.24 | -17.52 |
| EPS Basic Continuous Ops | -25.49 | -24.37 | -20.61 | -20.21 | -17.53 |
| EPS Diluted Total Ops | -25.52 | -24.40 | -20.64 | -20.24 | -17.52 |
| EPS Diluted Continuous Ops | -25.49 | -24.37 | -20.61 | -20.21 | -17.53 |
| EPS Diluted Before Non-Recurring Items | -25.52 | -24.40 | -20.64 | -20.24 | -17.52 |
| EBITDA(a) | $-137,711 | $-131,582 | $-85,044 | $-66,943 | $-51,594 |